NAFDAC Shuts Kaduna Yoghurt Depot, Gives Reasons for Action

• NAFDAC Kaduna shut a yoghurt and flavoured drink depot after inspectors found it operating in unhygienic conditions
• The agency reported that the facility posed a high risk of contamination due to poor handling and safety lapses
• Officials confirmed that more regulatory checks were underway across Kaduna to enforce hygiene compliance

NAFDAC Kaduna has closed a yoghurt and flavoured drink depot after inspectors uncovered operations carried out under unhygienic conditions. The agency said the environment posed a serious risk to consumers due to the likelihood of contamination.

According to NAFDAC, the shutdown followed an enforcement visit where officials documented poor handling practices and general neglect of basic safety standards.

The agency said the operators failed to meet requirements for the storage and distribution of consumable products.

NAFDAC stated that the decision to seal the depot was necessary to prevent compromised products from reaching the market.

The agency added that the action aligned with its mandate to safeguard public health through routine surveillance and enforcement.

Read also

FG Declares Lagos Best State in 2025 PEBEC Ease of Doing Business

NAFDAC withdraws approval for Pharmaceutical products

Earlier, Legit.ng reported that NAFDAC had announced the withdrawal, suspension, and cancellation of approval for several pharmaceutical products.

This decision, shared via a post on X, affects the manufacture, importation, exportation, distribution, advertisement, sale, and use of these products within Nigeria.

List of Withdrawn Products

1. Abacavir Sulfate/Lamivudine Dispersible Tablets 60mg/30mg Tablets – NAFDAC Number: C4-1180. Active Ingredient: Abacavir sulfate and Lamivudine. Market Authorization Holder: Healthline Limited.
2. Amaryl M Tablets – NAFDAC Number: A4-2619. Active Ingredient: Glimepiride + Metformin Hydrochloride. Market Authorization Holder: Sanofi Aventis Nigeria Ltd.
3. Amaryl M SR Tablets – NAFDAC Number: A4-7296. Active Ingredient: Glimepiride + Metformin Hydrochloride. Market Authorization Holder: Sanofi Aventis Nigeria Ltd.
4. Aprovasc 150mg/5mg Tablets – NAFDAC Number: B4-2687. Active Ingredient: Amlodipine Besylate + Aprovasc. Market Authorization Holder: Sanofi Aventis Nigeria Ltd.
5. Artemether/Lumefantrine 40mg/240mg Tablets – NAFDAC Number: B4-5745. Active Ingredient: Artemether/Lumefantrine 40mg/240mg. Market Authorization Holder: Healthline Limited.
6. ASAQ (Artesunate Amodiaquine Winthrop) 100mg/270mg Tablets – NAFDAC Number: A4-3357. Active Ingredient: Artesunate Amodiaquine Winthrop 100mg/270mg. Market Authorization Holder: Sanofi Aventis Nigeria Ltd.
7. ASAQ (Artesunate Amodiaquine Winthrop) 25mg/67.5mg Tablets – NAFDAC Number: A4-3406. Active Ingredient: Artesunate Amodiaquine Winthrop 25mg/67.5mg. Market Authorization Holder: Sanofi Aventis Nigeria Ltd.
8. ASAQ (Artesunate Amodiaquine Winthrop) 50mg/135mg Tablets – NAFDAC Number: A4-3405. Active Ingredient: Artesunate Amodiaquine Winthrop 50mg/135mg. Market Authorization Holder: Sanofi Aventis Nigeria Ltd.
9. Betopic Eye Drop – NAFDAC Number: 04 2404. Active Ingredient: Batexolol Hydrochloride. Market Authorization Holder: Novartis.
10. Coaprovel 300mg/25mg Tablets – NAFDAC Number: B4-2317. Active Ingredient: Hydrochlorothiazide + Irbesartan. Market Authorization Holder: Sanofi Aventis Nigeria Ltd.
11. Combination 3 Tablets – NAFDAC Number: A4-6459. Active Ingredient: Estrogen, Progestin. Market Authorization Holder: Bayer East Africa Limited.
12. Efavirenz 600mg Tablets – NAFDAC Number: A4-1318. Active Ingredient: Efavirenz 600mg. Market Authorization Holder: Healthline Limited.
13. Elisca Eye Drop – NAFDAC Number: 04 2461. Active Ingredient: Chloramphenicol Eye Drop. Market Authorization Holder: Sanofi Aventis Nigeria Ltd.
14. Flagyl Suspension – NAFDAC Number: A4-3947. Active Ingredient: Metronidazole Benzoate. Market Authorization Holder: Sanofi Aventis Nigeria Ltd.
15. Flagyl Tablet 400mg – NAFDAC Number: 04 5566. Active Ingredient: Metronidazole. Market Authorization Holder: Sanofi Aventis Nigeria Ltd.
16. Iliadin Adult 0.05% Metered Nose Spray – NAFDAC Number: B4-9913. Active Ingredient: Oxymetazoline HCl 0.05%M/V. Market Authorization Holder: Fensyl MHP Consulting Ltd.
17. Iliadin Baby 0.01% Nose Drops – NAFDAC Number: C4-0106. Active Ingredient: Oxymetazoline HCl 0.01%M/V. Market Authorization Holder: Fensyl MHP Consulting Ltd.
18. Iliadin Kids 0.025% Nose Drops – NAFDAC Number: B4-9912. Active Ingredient: Oxymetazoline HCl 0.025%M/V. Market Authorization Holder: Fensyl MHP Consulting Ltd.
19. Invanz 1g Injections – NAFDAC Number: 04 8118. Active Ingredient: Ertapenem 1g. Market Authorization Holder: MSD Idea Pharmaceuticals Nigeria Ltd.
20. Invega (Paliperidone) 3mg Extended Release Tablets – NAFDAC Number: B4-8223. Active Ingredient: Paliperidone. Market Authorization Holder: Janssen Pharmaceutical Companies.

Read also

Nigeria Customs seizes 184,000 litres of petrol worth N181 million from smugglers

NAFDAC Deregisters, Bans Popular Beauty Soap

Meanwhile, Legit.ng earlier reported that the National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert regarding the recall of Dove Beauty Cream Bar Soap (100g) with batch number 81832M 08.

The product, manufactured in Germany, has been found to contain Butylphenyl Methylpropional (BMHCA), a chemical impurity that poses significant health risks.

Source: Legit.ng